2022 抗凝论坛临床指南: COVID-19流行期间的血栓栓塞预防和抗凝治疗

2022-05-17 抗凝论坛 J Thromb Thrombolysis

2022年5月,抗凝论坛(Anticoagulation Forum)更新了COVID-19流行期间的血栓栓塞预防和抗凝治疗指南。血栓栓塞是住院COVID-19患者常见的致命性影响,一些专家共识和指南

中文标题:

2022 抗凝论坛临床指南: COVID-19流行期间的血栓栓塞预防和抗凝治疗

英文标题:

Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum

发布机构:

抗凝论坛

发布日期:

2022-05-17

简要介绍:

2022年5月,抗凝论坛(Anticoagulation Forum)更新了COVID-19流行期间的血栓栓塞预防和抗凝治疗指南。血栓栓塞是住院COVID-19患者常见的致命性影响,一些专家共识和指南强烈鼓励因COVID-19住院的患者进行预防性抗凝治疗。本文主要针对COVID-19患者抗凝治疗提供最新指导。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2022 抗凝论坛临床指南: COVID-19流行期间的血栓栓塞预防和抗凝治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=b4abf1c002a409e2, title=2022 抗凝论坛临床指南: COVID-19流行期间的血栓栓塞预防和抗凝治疗, enTitle=Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum, guiderFrom=J Thromb Thrombolysis, authorId=0, author=, summary=2022年5月,抗凝论坛(Anticoagulation Forum)更新了COVID-19流行期间的血栓栓塞预防和抗凝治疗指南。血栓栓塞是住院COVID-19患者常见的致命性影响,一些专家共识和指南, cover=https://img.medsci.cn/20220518/1652873558020_1608702.jpg, journalId=0, articlesId=null, associationId=2731, associationName=抗凝论坛, associationIntro=抗凝论坛(Anticoagulation Forum), copyright=0, guiderPublishedTime=Tue May 17 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">2022年5月,抗凝论坛(Anticoagulation Forum)更新了COVID-19流行期间的血栓栓塞预防和抗凝治疗指南。血栓栓塞是住院COVID-19患者常见的致命性影响,一些专家共识和指南强烈鼓励因COVID-19住院的患者进行预防性抗凝治疗。本文主要针对COVID-19患者抗凝治疗提供最新指导。</span></p>, tagList=[TagDto(tagId=991, tagName=血栓栓塞), TagDto(tagId=1182, tagName=抗凝治疗), TagDto(tagId=99632, tagName=Covid-19)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10821, appHits=129, showAppHits=0, pcHits=598, showPcHits=10683, likes=1, shares=21, comments=2, approvalStatus=1, publishedTime=Thu May 19 15:27:00 CST 2022, publishedTimeString=2022-05-17, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=dajiong, createdTime=Wed May 18 19:30:51 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 16:19:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 抗凝论坛临床指南: COVID-19流行期间的血栓栓塞预防和抗凝治疗.pdf)])
2022 抗凝论坛临床指南: COVID-19流行期间的血栓栓塞预防和抗凝治疗.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1221649, encodeId=840812216495e, content=受教, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5dea3836967, createdName=路人卯, createdTime=Sun May 22 22:05:57 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220969, encodeId=812812209692b, content=11, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8af8162359, createdName=ms4000001629932559, createdTime=Thu May 19 17:08:16 CST 2022, time=2022-05-19, status=1, ipAttribution=)]
    2022-05-22 路人卯

    受教

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1221649, encodeId=840812216495e, content=受教, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5dea3836967, createdName=路人卯, createdTime=Sun May 22 22:05:57 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220969, encodeId=812812209692b, content=11, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8af8162359, createdName=ms4000001629932559, createdTime=Thu May 19 17:08:16 CST 2022, time=2022-05-19, status=1, ipAttribution=)]
    2022-05-19 ms4000001629932559

    11

    0